N-Vascular Technology Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 75.06%
- Profit Growth -4.16%
- Ebitda -167.16%
- Net Worth 58.21%
- Total Assets 52.28%
About N-Vascular Technology
N-Vascular Technology Private Limited (NTPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 June 2016 (Eight years and seven months 19 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Kagadada and Sureschandra Kagadada serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2016PTC282667
-
Company No.
282667
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Jun 2016
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at N-Vascular Technology?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Kagadada
|
Director | 21-Jun-2016 | Current |
|
Sureschandra Kagadada
|
Director | 21-Jun-2016 | Current |
Financial Performance of N-Vascular Technology.
N-Vascular Technology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 75.06% increase. The company also saw a slight decrease in profitability, with a 4.16% decrease in profit. The company's net worth Soared by an impressive increase of 58.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of N-Vascular Technology?
Unlock access to N-Vascular Technology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Zweck Creations Private LimitedVishal Kagadada is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at N-Vascular Technology?
Unlock and access historical data on people associated with N-Vascular Technology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of N-Vascular Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped N-Vascular Technology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
